missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Clozapine N-oxide
Description
Metabolite of clozapine (Cat. No. 0444). Activates human muscarinic designer receptors (DREADDs) in vitro. Silences hippocampal neurons expressing hM4 DREADDs in vitro. Activates Gs-linked DREADDS- AgRP in mice via intracerebroventricular (i.c.v) injection. Shown to be a P-glycoprotein (P-gp) efflux pump substrate. Other potent and selective hM3Dq DREADD agonists available: DREADD agonist 21 and Perlapine .
Water soluble salt also available.
This product contains 1 molar equivalent of ethanol.
Spécification
Spécification
| Nom chimique ou matériau | Clozapine N-oxide |
| Plage de pourcentage du dosage | >98% |
| Quantité | 50 mg |
| Gamme de produits | Tocris |
| Poids de la formule | 342.82 |
| Pureté | >99% |
| Poids moléculaire | 342.827 |
Nom du produit
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?